Journal
EXPERIMENTAL CELL RESEARCH
Volume 313, Issue 18, Pages 3832-3839Publisher
ELSEVIER INC
DOI: 10.1016/j.yexcr.2007.08.017
Keywords
racl; melanoma; proliferation; NF kappa B; small GTpase; metastasis
Categories
Ask authors/readers for more resources
Molecular mechanisms underlying the different capacity of two in vivo selected human melanoma cell variants to form experimental metastases were studied. The doubling times of the FEMX-I and FEMX-V cell sublines in vitro were 15 and 25 h, respectively. The invasive capacity of FEMX-I cells was 8-fold higher than FEMX-V cells, and the time to form approximately 10 mm s.c. tumors in nude mice was 21 versus 35 days. FEMX-I displayed a spindle-like formation in vitro, whereas FEMX-V cells had a rounded shape. Hence, we examined known determinants of cell shape and proliferation, the small GTPases. The four studied showed equal expression in both cell types, but Rac1 activity was significantly decreased in FEMX-V cells. Rac1 stimulates NF kappa B, and we found that endogenous NF kappa B activity of FEMX-V cells was 2% of that of FEMX-I cells. Inhibition of Rac1 resulted in blocked NF kappa B activity. Specific inhibition of either Rac1 or NF kappa B significantly reduced proliferation and invasion of FEMX-I cells, the more pronounced effects observed with Rac1 inhibition. These data indicate that Rac1 activity in FEMX cells regulates cell proliferation and invasion, in part via its effect on NF kappa B, signifying Rac1 as a key molecule in melanoma progression and metastasis. (C) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available